{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:15:34Z","timestamp":1790712934190,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,9]],"date-time":"2022-02-09T00:00:00Z","timestamp":1644364800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.ejca.2022.01.030","type":"journal-article","created":{"date-parts":[[2022,3,17]],"date-time":"2022-03-17T19:54:36Z","timestamp":1647546876000},"page":"208-218","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"special_numbering":"C","title":["Correlation between drug sensitivity profiles of circulating tumour cell-derived organoids and clinical treatment response in patients with pancreatic ductal adenocarcinoma"],"prefix":"10.1016","volume":"166","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2908-7704","authenticated-orcid":false,"given":"Yuan-Hung","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Ping","family":"Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nai-Chi","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rheun-Chuan","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2123-8264","authenticated-orcid":false,"given":"Chung-Pin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yee","family":"Chao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Ming","family":"Shyr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7038-6146","authenticated-orcid":false,"given":"Shin-E","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shih-Chin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng-Hsuan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Hsuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Mei","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shih-Ming","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Hue","family":"Yen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2403-1843","authenticated-orcid":false,"given":"Jeng-You","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuan-Der","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huey-En","family":"Tseng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Ruey","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jui-Hsiang","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeng-Fong","family":"Chiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Burnouf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin-Ju","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng-Yuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4247-1981","authenticated-orcid":false,"given":"Long-Sheng","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2022.01.030_bib1","first-page":"559","article-title":"The implication of liquid biopsies to predict chemoresistance in pancreatic cancer","volume":"4","author":"Pietri","year":"2021","journal-title":"Cancer Drug Resist"},{"key":"10.1016\/j.ejca.2022.01.030_bib2","doi-asserted-by":"crossref","first-page":"389","DOI":"10.3390\/biomedicines9040389","article-title":"The latest advancement in pancreatic ductal adenocarcinoma therapy: a review article for the latest guidelines and novel therapies","volume":"9","author":"Elsayed","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.ejca.2022.01.030_bib3","doi-asserted-by":"crossref","first-page":"10","DOI":"10.14740\/wjon1166","article-title":"Epidemiology of pancreatic cancer: global trends, etiology and risk factors","volume":"10","author":"Rawla","year":"2019","journal-title":"World J Oncol"},{"key":"10.1016\/j.ejca.2022.01.030_bib4","first-page":"209","article-title":"CA Global cancer statistics 2020, GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA A Cancer J Clin"},{"key":"10.1016\/j.ejca.2022.01.030_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000453086","article-title":"The evolving role of biomarkers in personalized lung cancer therapy","volume":"93","author":"Sharma","year":"2017","journal-title":"Respiration"},{"key":"10.1016\/j.ejca.2022.01.030_bib6","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s13058-019-1159-3","article-title":"On-treatment biomarkers can improve prediction of response to neoadjuvant chemotherapy in breast cancer","volume":"21","author":"Bownes","year":"2019","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.ejca.2022.01.030_bib7","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1056\/NEJMoa1903387","article-title":"Maintenance olaparib for germline BRCA-mutated metastatic pancreatic cancer","volume":"381","author":"Golan","year":"2019","journal-title":"N Engl J Med"},{"issue":"15_suppl","key":"10.1016\/j.ejca.2022.01.030_bib8","doi-asserted-by":"crossref","first-page":"4132","DOI":"10.1200\/JCO.2019.37.15_suppl.4132","article-title":"Homologous recombination deficiency (HRD): a biomarker for first-line (1L) platinum in advanced pancreatic ductal adenocarcinoma (PDAC)","volume":"37","author":"Park","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2022.01.030_bib9","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.2147\/CMAR.S211151","article-title":"BRCA mutations in pancreas cancer: spectrum, current management, challenges and future prospects","volume":"12","author":"Wong","year":"2020","journal-title":"Cancer Manag Res"},{"key":"10.1016\/j.ejca.2022.01.030_bib10","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1002\/1878-0261.12537","article-title":"Liquid biopsy in pancreatic ductal adenocarcinoma: current status of circulating tumour cells and circulating tumour DNA","volume":"13","author":"Lee","year":"2019","journal-title":"Mol Oncol"},{"key":"10.1016\/j.ejca.2022.01.030_bib11","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.3390\/cancers11111659","article-title":"Circulating tumour cells in pancreatic cancer: current perspectives","volume":"11","author":"Martini","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.ejca.2022.01.030_bib12","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1136\/gutjnl-2016-311447","article-title":"Circulating tumour cells from patients with colorectal cancer have cancer stem cell hallmarks in ex\u00a0vivo culture","volume":"66","author":"Grillet","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.ejca.2022.01.030_bib13","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.3390\/cancers12061423","article-title":"Patient-derived in\u00a0vitro models for drug discovery in colorectal carcinoma","volume":"12","author":"Ramzy","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.ejca.2022.01.030_bib14","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1126\/science.1253533","article-title":"Cancer therapy. Ex\u00a0vivo culture of circulating breast tumour cells for individualized testing of drug susceptibility","volume":"345","author":"Yu","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.ejca.2022.01.030_bib15","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.cell.2014.08.016","article-title":"Organoid cultures derived from patients with advanced prostate cancer","volume":"159","author":"Gao","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.ejca.2022.01.030_bib16","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.bbcan.2017.12.005","article-title":"Circulating tumour cell-derived organoids: current challenges and promises in medical research and precision medicine","volume":"1869","author":"Praharaj","year":"2018","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"10.1016\/j.ejca.2022.01.030_bib17","doi-asserted-by":"crossref","first-page":"3394","DOI":"10.3390\/cancers12113394","article-title":"Ex\u00a0vivo expansion and drug sensitivity profiling of circulating tumour cells from patients with small cell lung cancer","volume":"12","author":"Lee","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.ejca.2022.01.030_bib18","doi-asserted-by":"crossref","first-page":"6076","DOI":"10.3390\/cancers13236076","article-title":"Ex\u00a0vivo expanded circulating tumour cells for clinical anti-cancer drug prediction in patients with head and neck cancer","volume":"13","author":"Lin","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.ejca.2022.01.030_bib19","series-title":"AJCC cancer staging manual","year":"2017"},{"key":"10.1016\/j.ejca.2022.01.030_bib20","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2022.01.030_bib21","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1080\/15384047.2016.1141839","article-title":"Identifying cancer origin using circulating tumour cells","volume":"17","author":"Lu","year":"2016","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.ejca.2022.01.030_bib22","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1080\/09537104.2020.1849603","article-title":"Extensive characterization of the composition and functional activities of five preparations of human platelet lysates for dedicated clinical uses","volume":"32","author":"Delila","year":"2021","journal-title":"Platelets"},{"key":"10.1016\/j.ejca.2022.01.030_bib23","doi-asserted-by":"crossref","first-page":"36845","DOI":"10.1038\/srep36845","article-title":"Binary colloidal crystals (BCCs) as a feeder-free system to generate human induced pluripotent stem cells (hiPSCs)","volume":"6","author":"Wang","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.ejca.2022.01.030_bib24","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.1158\/1078-0432.CCR-16-3083","article-title":"Clinically relevant concentrations of anticancer drugs: a guide for nonclinical studies","volume":"23","author":"Liston","year":"2017","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ejca.2022.01.030_bib25","doi-asserted-by":"crossref","first-page":"18162","DOI":"10.18632\/oncotarget.4216","article-title":"Erlotinib is effective in pancreatic cancer with epidermal growth factor receptor mutations: a randomized, open-label, prospective trial","volume":"6","author":"Wang","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejca.2022.01.030_bib26","first-page":"858","article-title":"Utility of HNF-1B and a panel of lineage-specific biomarkers to optimize the diagnosis of pancreatic ductal adenocarcinoma","volume":"11","author":"Bai","year":"2021","journal-title":"Am J Cancer Res"},{"key":"10.1016\/j.ejca.2022.01.030_bib27","doi-asserted-by":"crossref","first-page":"8105","DOI":"10.1038\/s41598-018-26526-x","article-title":"Mutations in BRCA1, BRCA2, and PALB2, and a panel of 50 cancer-associated genes in pancreatic ductal adenocarcinoma","volume":"8","author":"Takeuchi","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.ejca.2022.01.030_bib28","doi-asserted-by":"crossref","first-page":"15578","DOI":"10.18632\/oncotarget.3903","article-title":"Short-term expansion of breast circulating cancer cells predicts response to anti-cancer therapy","volume":"6","author":"Khoo","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejca.2022.01.030_bib29","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1038\/srep01259","article-title":"Isolation and retrieval of circulating tumour cells using centrifugal forces","volume":"3","author":"Hou","year":"2013","journal-title":"Sci Rep"},{"key":"10.1016\/j.ejca.2022.01.030_bib30","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1038\/nature06385","article-title":"Isolation of rare circulating tumour cells in cancer patients by microchip technology","volume":"450","author":"Nagrath","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.ejca.2022.01.030_bib31","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1158\/1078-0432.CCR-06-1695","article-title":"Detection of circulating tumour cells in peripheral blood of patients with metastatic breast cancer: a validation study of the CellSearch system","volume":"13","author":"Riethdorf","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ejca.2022.01.030_bib32","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/nrc822","article-title":"Epithelial-mesenchymal transitions in tumour progression","volume":"2","author":"Thiery","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ejca.2022.01.030_bib33","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1126\/science.1228522","article-title":"Circulating breast tumour cells exhibit dynamic changes in epithelial and mesenchymal composition","volume":"339","author":"Yu","year":"2013","journal-title":"Science"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804922000636?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804922000636?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T20:36:25Z","timestamp":1760733385000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804922000636"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":33,"alternative-id":["S0959804922000636"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2022.01.030","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Correlation between drug sensitivity profiles of circulating tumour cell-derived organoids and clinical treatment response in patients with pancreatic ductal adenocarcinoma","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2022.01.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}